| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Dupilumab^trough | LP434542-9 |
| PROPERTY | MCnc | LP6827-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | Qn | LP7753-9 |
| METHOD_TYP | LC/MS/MS | LP95062-3 |
| parent | Dupilumab | Serum or Plasma | Drug toxicology | LP434877-9 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| EXAMPLE_UNITS | mg/L | |
| EXAMPLE_UCUM_UNITS | mg/L | |
| UNITSREQUIRED | N |
| LONG_COMMON_NAME | en-US | Dupilumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough |
| LONG_COMMON_NAME | en-US | Dupilumab [Mass/volume] in Serum or Plasma by LC/MS/MS --trough |
| SHORTNAME | en-US | Dupilumab Trough SerPl LC/MS/MS-mCnc |
| ConsumerName | en-US | Dupilumab trough, Blood |
| LONG_COMMON_NAME | fr-FR | Dupilumab taux résiduel [Masse/Volume] Sérum/Plasma ; Numérique ; LC/MS/MS |
| LONG_COMMON_NAME | nl-NL | Dupilumab^dalspiegel [massa/volume] in serum of plasma d.m.v. LC/MS/MS |
LOINC Version: 2.77
FHIR